The Wearable Worked. The Outcomes Didn't Move.
Rodríguez-Molinero, Pérez-López, Caballol and colleagues enrolled 156 patients with Parkinson's disease and motor fluctuations across 35 Spanish neurology centers. Neurologists were cluster-randomized into three approaches for guiding medication adjustments over 26 weeks: clinical visit data alone, the Hauser diary, or the STAT-ON Parkinson's Holter. The primary outcome was change in daily OFF time at 26 weeks. Secondary outcomes included ON time, dyskinesia duration, and quality-of-life scores on the PDQ-8. Published in npj Parkinson's Disease in August 2025, this is one of the largest randomized evaluations of a wearable device for medication guidance in Parkinson's disease.
Change in daily OFF time was similar across all three groups at 26 weeks. ON time, dyskinesia duration, and PDQ-8 scores followed the same pattern.
The STAT-ON is a waist-worn inertial measurement unit that records motor state continuously throughout the day. After a monitoring period, it generates a PDF report with graphical summaries showing the percentage of time spent in ON, OFF, and intermediate motor states, along with counts of freezing of gait episodes and dyskinesia periods. The report gives neurologists a structured, quantified picture of motor state distribution over time. Clinicians use it to inform medication decisions at the follow-up visit. The device produces data visualization; it generates no treatment recommendations.
The ON/OFF classification algorithm has been validated against the Hauser diary with good accuracy. The technology was a reasonable choice for the question this trial posed. Three arms that moved equivalently was the result.
Understanding that equivalence requires attention to where this trial was conducted.
The 35 participating centers were academic and specialist neurology clinics across Spain. Clinicians at these centers manage substantial Parkinson's patient volumes and have long experience with the phenomenology of wearing-off, delayed ON, and peak-dose dyskinesia. Their baseline level of clinical reasoning about motor fluctuations was already high. A tool that adds objective structure to something clinicians are already doing with precision has limited room to shift population-level outcomes in that context. A ceiling effect is a plausible frame for this result: the intervention adds precision to a workflow that was already functioning at a high level.
The equivalence of the Hauser diary arm adds another dimension. All three groups showed similar improvement trajectories over 26 weeks, including the clinical visit arm. One dynamic likely operating across all three arms simultaneously was the Hawthorne effect. Patients in every group were being formally observed: completing structured monitoring with more diligence than they might apply outside a trial, attending visits with more structured assessment than typical, having their motor state reviewed with close attention. Formal observation, applied consistently across all three arms, likely elevated engagement and self-monitoring throughout. When all three arms benefit from the same attentional effect, the differences between them narrow.
The specialist academic clinic is one end of a wide spectrum of Parkinson's care. A general neurology practice where a clinician manages a small number of Parkinson's patients within a large and varied caseload operates very differently. So does a rural setting where specialist access is limited to one or two visits per year, or a telehealth model where clinical assessment is bounded by what a video encounter allows.
In these settings, a structured PDF report showing four weeks of motor state distribution, freezing episodes, and dyskinesia periods provides information beyond what the clinical encounter alone can generate. The clinician has fewer accumulated data points, less familiarity with a given patient's specific fluctuation pattern, and greater reliance on self-report that may be incomplete. The information gap is wider. A tool that closes that gap has more room to shift clinical decisions and, downstream, outcomes.
Testing that hypothesis requires trials designed for the settings where the gap exists. The 35-center design here was, by construction, a test in contexts well-positioned to show a ceiling effect. The meaningful next question is what happens when the same tools are studied where the baseline is lower and the floor for improvement is higher.
The authors suggest that value from continuous motor monitoring may emerge over longer time horizons, or through care models structured around remote and asynchronous review. That framing is consistent with the ceiling effect interpretation. Specialists doing quarterly structured visits in high-volume academic practices may see modest incremental benefit from better data. Clinicians doing fewer visits with less accumulated context may see substantially more.
Building the evidence base in that direction means designing trials in general neurology practices, community hospitals, and telehealth-first settings. It also means structuring the care models surrounding these tools before randomization, so the workflow for responding to the data is defined in advance rather than left to each center's discretion. That is a different research question than the one this trial answered. It is a more consequential one for the field to pursue.
Rodríguez-Molinero A, Pérez-López C, Caballol N et al. "Parkinson's disease medication adjustments based on wearable device information compared to other methods: randomized clinical trial." npj Parkinson's Disease 11, 249 (2025). https://doi.org/10.1038/s41531-025-00977-2